Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
estrogen nuclear receptor alpha | 26 | 0 | 0 | 26 |
Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
Free fatty acid receptor 2 | 0 | 1 | 1 | 2 |
Tyrosine-protein kinase Lck | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Fyn | 0 | 0 | 1 | 1 |
Fibrinogen C domain-containing protein 1 | 0 | 1 | 0 | 1 |
Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 11 | 0 | 0 | 11 |
Chain B, HADH2 protein | 11 | 0 | 0 | 11 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 4 | 0 | 0 | 4 |
Chain A, Ferritin light chain | 5 | 0 | 0 | 5 |
Thymidine kinase | 0 | 2 | 0 | 2 |
thioredoxin reductase | 12 | 0 | 0 | 12 |
phosphopantetheinyl transferase | 11 | 0 | 0 | 11 |
GLS protein | 10 | 0 | 0 | 10 |
TDP1 protein | 25 | 0 | 0 | 25 |
Smad3 | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 12 | 0 | 0 | 12 |
EWS/FLI fusion protein | 14 | 0 | 0 | 14 |
arylsulfatase A | 7 | 0 | 0 | 7 |
euchromatic histone-lysine N-methyltransferase 2 | 23 | 0 | 0 | 23 |
activating transcription factor 6 | 8 | 0 | 0 | 8 |
Histone H2A.x | 14 | 0 | 0 | 14 |
Bloom syndrome protein isoform 1 | 8 | 0 | 0 | 8 |
hemoglobin subunit beta | 4 | 0 | 0 | 4 |
atrial natriuretic peptide receptor 1 precursor | 3 | 0 | 0 | 3 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
lamin isoform A-delta10 | 16 | 0 | 0 | 16 |
Solute carrier family 22 member 1 | 0 | 7 | 0 | 9 |
ATP-binding cassette sub-family C member 3 | 0 | 24 | 0 | 24 |
Multidrug resistance-associated protein 4 | 0 | 24 | 0 | 25 |
Solute carrier family 22 member 6 | 0 | 3 | 0 | 4 |
Bile salt export pump | 0 | 7 | 0 | 7 |
Bile salt export pump | 0 | 34 | 0 | 34 |
Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 1 | 0 | 2 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 2 |
Cytochrome P450 2C9 | 0 | 13 | 0 | 14 |
Cytochrome P450 2J2 | 0 | 7 | 0 | 8 |
Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
Purine nucleoside phosphorylase | 0 | 0 | 3 | 3 |
Solute carrier family 22 member 6 | 0 | 0 | 0 | 3 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 3 |
Canalicular multispecific organic anion transporter 1 | 0 | 25 | 0 | 26 |
Thymidine kinase | 0 | 2 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 12 | 0 | 0 | 12 |
Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
Chain A, 2-oxoglutarate Oxygenase | 10 | 0 | 0 | 10 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
AR protein | 25 | 0 | 0 | 25 |
apical membrane antigen 1, AMA1 | 4 | 0 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 2 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 4 | 0 | 0 | 4 |
DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
DNA polymerase iota isoform a (long) | 10 | 0 | 0 | 10 |
urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
plasminogen precursor | 4 | 0 | 0 | 4 |
urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 0 | 4 |
Solute carrier family 15 member 1 | 0 | 7 | 0 | 7 |
Solute carrier family 15 member 1 | 0 | 3 | 0 | 3 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 3 |
Solute carrier family 15 member 2 | 0 | 5 | 0 | 5 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 5 | 0 | 6 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
acid sphingomyelinase | 2 | 0 | 0 | 2 |
GLI family zinc finger 3 | 23 | 0 | 0 | 23 |
retinoic acid nuclear receptor alpha variant 1 | 21 | 0 | 0 | 21 |
farnesoid X nuclear receptor | 12 | 0 | 0 | 12 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 8 | 0 | 0 | 8 |
chromobox protein homolog 1 | 12 | 0 | 0 | 12 |
thyroid hormone receptor beta isoform 2 | 16 | 0 | 0 | 16 |
DNA polymerase beta | 4 | 0 | 0 | 4 |
geminin | 21 | 0 | 0 | 21 |
Carbonic anhydrase 1 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 2 | 0 | 5 | 1 | 6 |
60 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Beta-lactamase OXA-7 | 0 | 0 | 0 | 2 |
Spike glycoprotein | 14 | 0 | 1 | 15 |
10 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Angiopoietin-1 receptor | 0 | 0 | 2 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 3 | 0 | 3 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 2 |
Efflux transporter | 0 | 1 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 3 |
Class D beta-lactamase | 0 | 0 | 0 | 2 |
60 kDa chaperonin | 0 | 3 | 0 | 3 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
10 kDa chaperonin | 0 | 3 | 0 | 3 |
Metallo-b-lactamase | 0 | 0 | 0 | 3 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 3 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 2 |
ATP-dependent phosphofructokinase | 9 | 0 | 0 | 9 |
ATAD5 protein, partial | 8 | 0 | 0 | 8 |
Fumarate hydratase | 7 | 0 | 0 | 7 |
USP1 protein, partial | 11 | 0 | 0 | 11 |
PPM1D protein | 5 | 0 | 0 | 5 |
Thrombopoietin | 3 | 0 | 0 | 3 |
signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 6 | 0 | 0 | 6 |
regulator of G-protein signaling 4 | 5 | 0 | 0 | 5 |
polyprotein | 7 | 0 | 0 | 7 |
putative alpha-glucosidase | 1 | 0 | 0 | 1 |
alpha-galactosidase | 3 | 0 | 0 | 3 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 7 | 0 | 0 | 7 |
cytochrome P450 2C9 precursor | 6 | 0 | 0 | 6 |
D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
flap endonuclease 1 | 7 | 0 | 0 | 7 |
ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase mTOR isoform 1 | 5 | 0 | 0 | 5 |
cytochrome P450 3A4 isoform 1 | 10 | 0 | 0 | 10 |
caspase-1 isoform alpha precursor | 3 | 0 | 0 | 3 |
muscarinic acetylcholine receptor M1 | 9 | 0 | 0 | 9 |
lethal factor (plasmid) | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit pi | 10 | 3 | 0 | 13 |
Interferon beta | 16 | 0 | 0 | 16 |
Integrin beta-3 | 4 | 0 | 0 | 4 |
Integrin alpha-IIb | 4 | 0 | 0 | 4 |
Cytochrome P450 2D6 | 0 | 6 | 0 | 7 |
DNA topoisomerase 2-alpha | 0 | 3 | 2 | 17 |
Gamma-aminobutyric acid receptor subunit beta-1 | 10 | 3 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit delta | 10 | 3 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 10 | 3 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 10 | 3 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 10 | 3 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 10 | 3 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 10 | 3 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 10 | 3 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 10 | 3 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 10 | 3 | 0 | 13 |
Histamine H2 receptor | 11 | 1 | 0 | 14 |
D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 5 | 0 | 5 |
Caspase-7 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 10 | 3 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit beta-3 | 10 | 3 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit beta-2 | 10 | 3 | 0 | 13 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
DNA topoisomerase 2-beta | 0 | 2 | 2 | 11 |
Aldehyde oxidase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 12 | 0 | 13 |
GABA theta subunit | 10 | 3 | 0 | 13 |
Ataxin-2 | 18 | 0 | 0 | 18 |
Gamma-aminobutyric acid receptor subunit epsilon | 10 | 3 | 0 | 13 |
Aldehyde oxidase 1 | 0 | 2 | 0 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
NFKB1 protein, partial | 3 | 0 | 0 | 3 |
cytochrome P450 2C19 precursor | 5 | 0 | 0 | 5 |
Cytochrome P450 3A4 | 0 | 9 | 1 | 13 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 17 | 0 | 0 | 17 |
glucocorticoid receptor [Homo sapiens] | 19 | 0 | 0 | 19 |
retinoid X nuclear receptor alpha | 19 | 0 | 0 | 19 |
pregnane X nuclear receptor | 20 | 0 | 0 | 20 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 2 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M2 | 0 | 4 | 2 | 9 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 2 | 8 |
Muscarinic acetylcholine receptor M1 | 0 | 5 | 1 | 8 |
Muscarinic acetylcholine receptor M3 | 0 | 5 | 1 | 8 |
Muscarinic acetylcholine receptor M4 | 0 | 5 | 1 | 8 |
Muscarinic acetylcholine receptor M5 | 0 | 6 | 1 | 9 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 1 | 7 |
Muscarinic acetylcholine receptor M2 | 0 | 5 | 1 | 9 |
Muscarinic acetylcholine receptor M1 | 0 | 4 | 2 | 9 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 2 | 8 |
Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 5 | 1 | 6 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 2 |
Muscarinic acetylcholine receptor | 0 | 2 | 1 | 3 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 9 | 0 | 0 | 9 |
interleukin 8 | 3 | 0 | 0 | 3 |
acetylcholinesterase | 9 | 0 | 0 | 9 |
RAR-related orphan receptor gamma | 18 | 0 | 0 | 18 |
SMAD family member 2 | 6 | 0 | 0 | 6 |
SMAD family member 3 | 6 | 0 | 0 | 6 |
Microtubule-associated protein tau | 11 | 0 | 0 | 11 |
thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
estrogen-related nuclear receptor alpha | 17 | 0 | 0 | 17 |
G | 12 | 0 | 0 | 12 |
P53 | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 13 | 0 | 0 | 13 |
peroxisome proliferator activated receptor gamma | 14 | 0 | 0 | 14 |
IDH1 | 6 | 0 | 0 | 6 |
aryl hydrocarbon receptor | 9 | 0 | 0 | 9 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 12 | 0 | 0 | 12 |
thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 11 | 0 | 0 | 11 |
peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
heat shock protein beta-1 | 6 | 0 | 0 | 6 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 20 | 0 | 0 | 20 |
peripheral myelin protein 22 | 12 | 0 | 0 | 12 |
survival motor neuron protein isoform d | 10 | 0 | 0 | 10 |
M-phase phosphoprotein 8 | 5 | 0 | 0 | 5 |
muscleblind-like protein 1 isoform 1 | 6 | 0 | 0 | 6 |
Voltage-dependent calcium channel gamma-2 subunit | 14 | 0 | 0 | 14 |
HLA class I histocompatibility antigen, B alpha chain | 12 | 0 | 0 | 12 |
Cellular tumor antigen p53 | 17 | 0 | 0 | 17 |
Glutamate receptor 2 | 14 | 0 | 0 | 14 |
Nuclear receptor ROR-gamma | 4 | 0 | 0 | 4 |
Inositol hexakisphosphate kinase 1 | 12 | 0 | 0 | 12 |
ATPase family AAA domain-containing protein 5 | 15 | 0 | 0 | 15 |
Protein-arginine deiminase type-4 | 0 | 6 | 0 | 6 |
cytochrome P450 2C9, partial | 12 | 0 | 0 | 12 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 9 | 0 | 0 | 9 |
aldehyde dehydrogenase 1 family, member A1 | 17 | 0 | 0 | 17 |
bromodomain adjacent to zinc finger domain 2B | 7 | 0 | 0 | 7 |
vitamin D3 receptor isoform VDRA | 9 | 0 | 0 | 9 |
mitogen-activated protein kinase 1 | 6 | 0 | 0 | 6 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 3 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 2 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit A | 0 | 1 | 0 | 3 |
DNA gyrase subunit B | 0 | 1 | 0 | 3 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 2 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 3 | 0 | 6 |
Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
Integrase | 0 | 2 | 0 | 2 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 2 | 0 | 2 |
General amino-acid permease GAP1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 5 |
Beta-lactamase TEM | 0 | 2 | 0 | 3 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
Luciferase | 8 | 0 | 0 | 8 |
hypoxia-inducible factor 1 alpha subunit | 10 | 0 | 0 | 10 |
caspase 7, apoptosis-related cysteine protease | 6 | 0 | 0 | 6 |
estrogen receptor 2 (ER beta) | 10 | 0 | 0 | 10 |
progesterone receptor | 14 | 0 | 0 | 14 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 12 | 0 | 0 | 12 |
cytochrome P450 2D6 | 6 | 0 | 0 | 6 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 12 | 0 | 0 | 12 |
caspase-3 | 6 | 0 | 0 | 6 |
Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 4 | 0 | 0 | 4 |
potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
atrial natriuretic peptide receptor 2 precursor | 3 | 0 | 0 | 3 |
nuclear receptor ROR-gamma isoform 1 | 9 | 0 | 0 | 9 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 6 | 0 | 0 | 6 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 6 | 1 | 11 |
5-hydroxytryptamine receptor 1A | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2C | 0 | 5 | 0 | 6 |
Alpha-2A adrenergic receptor | 0 | 3 | 1 | 4 |
Calmodulin-1 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 5 | 0 | 8 |
5-hydroxytryptamine receptor 2A | 0 | 5 | 0 | 5 |
Alpha-1B adrenergic receptor | 0 | 5 | 1 | 6 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
D | 0 | 3 | 0 | 3 |
D(3) dopamine receptor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 4 | 0 | 4 |
Alpha-2B adrenergic receptor | 0 | 5 | 1 | 6 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Endothelin receptor type B | 1 | 1 | 0 | 2 |
D(1A) dopamine receptor | 0 | 2 | 0 | 3 |
D(4) dopamine receptor | 0 | 3 | 0 | 5 |
D(1B) dopamine receptor | 0 | 1 | 0 | 2 |
Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 5 | 1 | 6 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 4 |
Alpha-2A adrenergic receptor | 0 | 5 | 1 | 6 |
Alpha-1D adrenergic receptor | 0 | 5 | 1 | 6 |
Sodium-dependent noradrenaline transporter | 0 | 5 | 0 | 5 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 4 | 0 | 4 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
D(1B) dopamine receptor | 0 | 3 | 0 | 3 |
Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 6 |
5-hydroxytryptamine receptor 1B | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1D | 0 | 3 | 0 | 3 |
D(4) dopamine receptor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1F | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 4 | 1 | 5 |
Histamine H1 receptor | 0 | 1 | 1 | 2 |
Histamine H1 receptor | 0 | 3 | 0 | 3 |
Sodium-dependent serotonin transporter | 0 | 7 | 0 | 7 |
Sodium-dependent serotonin transporter | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 4 | 2 | 8 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 4 | 0 | 6 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 4 | 1 | 5 |
Alpha-1A adrenergic receptor | 0 | 5 | 1 | 6 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 3 | 0 | 4 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
Calmodulin | 0 | 1 | 2 | 3 |
Inositol monophosphatase 1 | 4 | 0 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 5 | 0 | 5 |
Sodium-dependent dopamine transporter | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 5 | 0 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
Transporter | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
D | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
Histamine H4 receptor | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Transporter | 0 | 4 | 0 | 4 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 3 |
Delta-type opioid receptor | 0 | 3 | 0 | 4 |
Kappa-type opioid receptor | 0 | 4 | 1 | 6 |
Mu-type opioid receptor | 0 | 8 | 3 | 12 |
Delta-type opioid receptor | 0 | 7 | 2 | 10 |
Kappa-type opioid receptor | 0 | 7 | 1 | 9 |
Mu-type opioid receptor | 0 | 4 | 1 | 7 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 2 | 2 |
endonuclease IV | 6 | 0 | 0 | 6 |
dopamine D1 receptor | 2 | 0 | 0 | 2 |
pregnane X receptor | 4 | 0 | 0 | 4 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 7 | 0 | 0 | 7 |
Glucocorticoid receptor | 0 | 8 | 2 | 15 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Glycine receptor subunit alpha-1 | 0 | 8 | 0 | 8 |
Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 8 | 0 | 8 |
Glycine receptor subunit alpha-2 | 0 | 8 | 0 | 8 |
Glycine receptor subunit alpha-3 | 0 | 8 | 0 | 8 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
67.9K protein | 4 | 0 | 0 | 4 |
LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform a | 5 | 0 | 0 | 5 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 8 | 0 | 0 | 8 |
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 3 | 0 | 3 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 3 | 0 | 3 |
nuclear receptor coactivator 3 isoform a | 0 | 3 | 0 | 3 |
Thymidine kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 3 | 0 | 4 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Deoxycytidine kinase | 0 | 0 | 0 | 1 |
Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
Cytidine deaminase | 0 | 1 | 0 | 2 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
Deoxynucleoside kinase | 0 | 1 | 0 | 1 |
Chain A, Breast cancer type 1 susceptibility protein | 2 | 0 | 0 | 2 |
Caspase-7 | 2 | 0 | 0 | 2 |
runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
caspase-3 | 2 | 0 | 0 | 2 |
core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 5 | 0 | 0 | 5 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 7 | 0 | 0 | 7 |
Transthyretin | 0 | 1 | 0 | 1 |
NADH-ubiquinone oxidoreductase chain 4 | 0 | 0 | 0 | 1 |
72 kDa type IV collagenase | 0 | 2 | 0 | 2 |
Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
Glutamate receptor 1 | 1 | 0 | 0 | 1 |
Glutamate receptor 3 | 1 | 0 | 0 | 1 |
Glutamate receptor 4 | 1 | 0 | 0 | 1 |
Platelet-activating factor receptor | 2 | 0 | 0 | 2 |
Multidrug resistance-associated protein 1 | 0 | 2 | 0 | 4 |
Histone deacetylase 1 | 0 | 1 | 0 | 1 |
Histone deacetylase 8 | 0 | 1 | 1 | 2 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 4 | 0 | 6 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 0 | 0 | 1 |
Regulatory protein E2 | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
DNA topoisomerase 2 | 0 | 0 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 0 | 4 |
Caspase-3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 0 | 4 |
DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 0 | 4 |
Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 0 | 4 |
Solute carrier organic anion transporter family member 1B3 | 0 | 4 | 0 | 6 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 0 | 4 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Skn7p | 0 | 0 | 0 | 1 |
nonstructural protein 1 | 4 | 0 | 0 | 4 |
Vpr | 1 | 0 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Amyloid-beta precursor protein | 1 | 0 | 0 | 1 |
Aromatase | 0 | 2 | 0 | 2 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
ClpP | 3 | 0 | 0 | 3 |
Transitional endoplasmic reticulum ATPase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Snq2p | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Major prion protein | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 4 subunit alpha | 0 | 3 | 0 | 4 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Envelope glycoprotein | 0 | 0 | 1 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Albumin | 0 | 0 | 2 | 2 |
15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
Menin | 0 | 1 | 0 | 1 |
Cocaine esterase | 0 | 2 | 0 | 2 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Procathepsin L | 0 | 0 | 1 | 1 |
Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Delta-type opioid receptor | 0 | 4 | 1 | 6 |
Mu-type opioid receptor | 0 | 4 | 1 | 8 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 3 | 1 | 4 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
UDP-glucose 6-dehydrogenase | 0 | 1 | 0 | 1 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
UDP-glucose 6-dehydrogenase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 3 |
Tumor necrosis factor | 0 | 1 | 1 | 2 |
Neuraminidase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Cystine/glutamate transporter | 0 | 2 | 0 | 2 |
Hydroxyacid oxidase 1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 4 |
large T antigen | 0 | 1 | 0 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 2 | 4 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Folate receptor beta | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Folate receptor alpha | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Histidine decarboxylase | 0 | 1 | 1 | 2 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
Bifunctional purine biosynthesis protein ATIC | 0 | 3 | 0 | 3 |
Kappa-type opioid receptor | 0 | 3 | 1 | 5 |
Reduced folate transporter | 0 | 2 | 0 | 2 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Pteridine reductase 1 | 0 | 1 | 0 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Androgen receptor | 0 | 5 | 0 | 5 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 0 | 1 | 1 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
pyruvate kinase | 1 | 0 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
pyruvate kinase PKM isoform a | 2 | 0 | 0 | 2 |
neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 1 | 0 | 0 | 1 |
Signal transducer and activator of transcription 3 | 0 | 1 | 0 | 1 |
Pyruvate-flavodoxin oxidoreductase | 0 | 1 | 0 | 1 |
Anoctamin-1 | 0 | 1 | 0 | 1 |
Mcl-1 | 0 | 1 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
Bifunctional cytochrome P450/NADPH--P450 reductase | 0 | 0 | 1 | 1 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
Bombesin receptor subtype-3 | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Fatty acid synthase | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 2 | 0 | 0 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
WD repeat-containing protein 5 | 0 | 1 | 0 | 1 |
Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase 2A | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Cytosolic endo-beta-N-acetylglucosaminidase | 0 | 1 | 0 | 1 |
Chain A, Bacterial leucyl aminopeptidase | 0 | 1 | 0 | 1 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
GALC protein | 2 | 0 | 0 | 2 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 14 | 0 | 1 | 0 | 1 |
Thermolysin | 0 | 2 | 0 | 3 |
Cholinesterase | 0 | 2 | 0 | 2 |
Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
Methionine aminopeptidase 2 | 0 | 1 | 0 | 1 |
Methionine aminopeptidase 1 | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase 1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase OXA-10 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
BlaVIM-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
Sterol 14-alpha-demethylase | 0 | 0 | 2 | 2 |
14-alpha sterol demethylase | 0 | 0 | 2 | 2 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 0 | 2 | 2 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
Sterol 14-alpha demethylase | 0 | 0 | 2 | 2 |
Sterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
14-alpha sterol demethylase | 0 | 0 | 2 | 2 |
14-alpha sterol demethylase | 0 | 0 | 2 | 2 |
luciferase | 0 | 0 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
Chain A, Glutathione S-transferase | 0 | 1 | 0 | 1 |
Interstitial collagenase | 0 | 1 | 0 | 1 |
Fibroblast growth factor 1 | 0 | 0 | 1 | 1 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 1 | 0 | 1 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 0 | 1 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Cytochrome P450 144 | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Cholesterol 24-hydroxylase | 0 | 2 | 1 | 3 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |